A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.
Bowden, C L
A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. [electronic resource] - Archives of general psychiatry May 2000 - 481-9 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0003-990X
10.1001/archpsyc.57.5.481 doi
Ambulatory Care
Antimanic Agents--adverse effects
Bipolar Disorder--drug therapy
Double-Blind Method
Drug Administration Schedule
Follow-Up Studies
Humans
Lithium Carbonate--adverse effects
Placebos
Psychiatric Status Rating Scales--statistics & numerical data
Secondary Prevention
Statistics, Nonparametric
Survival Analysis
Treatment Outcome
Valproic Acid--adverse effects
A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. [electronic resource] - Archives of general psychiatry May 2000 - 481-9 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0003-990X
10.1001/archpsyc.57.5.481 doi
Ambulatory Care
Antimanic Agents--adverse effects
Bipolar Disorder--drug therapy
Double-Blind Method
Drug Administration Schedule
Follow-Up Studies
Humans
Lithium Carbonate--adverse effects
Placebos
Psychiatric Status Rating Scales--statistics & numerical data
Secondary Prevention
Statistics, Nonparametric
Survival Analysis
Treatment Outcome
Valproic Acid--adverse effects